Market Value642,800,728
Total Holdings41
File Date2024-02-14
Original Filing (Click here)

All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings. These reports are called 13F reports. However, the filings are required the following quarter from the reporting period, which means that by the time the filing is made (and we see them), the information could be five months old.

For funds with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover, the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions are identified in the table. However, they are not required to report short positions.

Click the link icon to see the full transaction history.

Upgrade to unlock premium data and export to Excel .

Security Imputed
Share Price
Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
(USD x1000)
Current Value
(USD x1000)
Change
(Percent)
VRNA / Verona Pharma plc - Depositary Receipt (Common Stock)
SRRK / Scholar Rock Holding Corporation
VTVT / vTv Therapeutics Inc.
ALVR / AlloVir, Inc.
JANX / Janux Therapeutics, Inc.
LSAQ / LifeSci Acquisition II Corp
AVDL / Avadel Pharmaceuticals plc
ABVX / ABIVAX Société Anonyme - Depositary Receipt (Common Stock)
IMTX / Immatics N.V.
KRON / Kronos Bio, Inc.
TNGX / Tango Therapeutics, Inc.
HLVX / HilleVax, Inc.
RYTM / Rhythm Pharmaceuticals, Inc.
GRPH / Graphite Bio, Inc.
PEPG / PepGen Inc.
RYZB / RayzeBio, Inc.
SYRS / Syros Pharmaceuticals, Inc.
RAIN / Rain Enhancement Technologies Holdco, Inc.
IMCR / Immunocore Holdings plc - Depositary Receipt (Common Stock)
VTVT / vTv Therapeutics Inc.
ICPT / Intercept Pharmaceuticals Inc
PRME / Prime Medicine, Inc.
VIRX / Viracta Therapeutics, Inc.
ACRS / Aclaris Therapeutics, Inc.
IGMS / IGM Biosciences, Inc.
IOBT / IO Biotech, Inc.
DAWN / Day One Biopharmaceuticals, Inc.
SLRN / Acelyrin, Inc.
INZY / Inozyme Pharma, Inc.
NGNE / Neurogene Inc.
CRGX / CARGO Therapeutics, Inc.
STRO / Sutro Biopharma, Inc.
ZYME / Zymeworks Inc.
LPTX / Leap Therapeutics, Inc.
EYPT / EyePoint Pharmaceuticals, Inc.
GOSS / Gossamer Bio, Inc.
NUVB.WS / Panacea Acquisition Corp. - Equity Warrant
TERN / Terns Pharmaceuticals, Inc.
ALLK / Allakos Inc.
MLYS / Mineralys Therapeutics, Inc.
ACLX / Arcellx, Inc.
NKTX / Nkarta, Inc.
SRZNW / Surrozen, Inc. - Equity Warrant
LYRA / Lyra Therapeutics, Inc.
BOLT / Bolt Biotherapeutics, Inc.